{"result": "(\"entity\"<|>WOMEN'S HEALTH INITIATIVE<|>ORGANIZATION<|>The Women's Health Initiative is a long-term national health study aimed at addressing the most common causes of death, disability, and poor quality of life in older women.)\n##\n(\"entity\"<|>HORMONE REPLACEMENT THERAPY<|>EVENT<|>Hormone replacement therapy with estrogens is used in postmenopausal women to seek cardiovascular benefits but has associated risks.)\n##\n(\"entity\"<|>GROWTH HORMONE<|>EVENT<|>Growth hormone therapy is proposed as an anti-aging treatment for older adults, aiming to improve body composition and functional capacity.)\n##\n(\"entity\"<|>BASEDOW'S DISEASE<|>EVENT<|>Basedow's disease is an autoimmune disorder that can cause hyperthyroidism and may lead to spontaneous remission with treatment.)\n##\n(\"entity\"<|>MULTINODULAR GOITER<|>EVENT<|>Multinodular goiter is a condition that may require early treatment with I-131 due to low chances of spontaneous remission.)\n##\n(\"entity\"<|>PSA<|>EVENT<|>Prostate-specific antigen (PSA) is a marker used to evaluate prostate health and monitor for prostate cancer.)\n##\n(\"entity\"<|>OSTEOPOROSIS<|>EVENT<|>Osteoporosis is a condition characterized by weak and brittle bones, often seen in postmenopausal women.)\n##\n(\"entity\"<|>CARDIAC DISEASE<|>EVENT<|>Cardiac disease refers to various heart conditions that can be exacerbated by untreated hyperthyroidism.)\n##\n(\"entity\"<|>AGEING<|>EVENT<|>Ageing is the process of becoming older, which is associated with various physiological changes and health risks.)\n##\n(\"entity\"<|>HYPERTENSION<|>EVENT<|>Hypertension is a condition of elevated blood pressure that can be a risk factor for various health issues.)\n##\n(\"entity\"<|>DIABETES MELLITUS<|>EVENT<|>Diabetes mellitus is a metabolic disorder characterized by high blood sugar levels over a prolonged period.)\n##\n(\"relationship\"<|>HORMONE REPLACEMENT THERAPY<|>WOMEN'S HEALTH INITIATIVE<|>The Women's Health Initiative highlighted the risks associated with hormone replacement therapy in postmenopausal women<|>8)\n##\n(\"relationship\"<|>GROWTH HORMONE<|>AGEING<|>Growth hormone therapy is proposed as a treatment to counteract some effects of ageing<|>6)\n##\n(\"relationship\"<|>BASEDOW'S DISEASE<|>HYPERTENSION<|>Basedow's disease can lead to complications such as hypertension if not treated properly<|>4)\n##\n(\"relationship\"<|>MULTINODULAR GOITER<|>HYPERTENSION<|>Multinodular goiter can also lead to health complications, including hypertension<|>4)\n##\n(\"relationship\"<|>HORMONE REPLACEMENT THERAPY<|>OSTEOPOROSIS<|>Hormone replacement therapy is often considered for women with osteoporosis to mitigate risks<|>5)\n##\n(\"relationship\"<|>GROWTH HORMONE<|>DIABETES MELLITUS<|>Growth hormone therapy can have adverse effects, including the risk of developing diabetes mellitus<|>3)\n##\n(\"relationship\"<|>HYPERTENSION<|>CARDIAC DISEASE<|>Hypertension is a significant risk factor for developing cardiac disease<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: POLIGLANDULAR AUTOINMUNE Y MISCELÁNEA\n\ncalcio y de la calciuria, lo que facilita la disponibilidad de calcio al feto para su desarrollo esquelético, para el que necesita gran cantidad de calcio, sobre todo al final de la gestación.\n\nReferencias:\n- Hill DJ. Placental control of metabolic adaptations in the mother for an optimal pregnancy outcome. What goes wrong in gestational diabetes? Placenta. 2018;69:162-8.\n- Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A. Physiological changes in pregnancy. Cardiovasc J Africa. 2016;27(2):89-94. Disponible en: https://doi.org/10.5830/CVJA-2016-021\n\n## 41 En el envejecimiento, indique cuál de las siguientes afirmaciones es cierta:\n\nA. En personas de 65 años o más con hipertiroidismo subclínico con TSH < 0,1 mUI/l confirmada se aconseja tratamiento del hipertiroidismo únicamente si tienen enfermedad cardíaca.\nB. En mujeres en edad menopáusica, el tratamiento hormonal sustitutivo con estrógenos aumenta progresivamente el riesgo de cáncer de mama y se ve reducido al añadir progesterona.\nC. El tratamiento con GH en personas mayores mejora la capacidad funcional cuando se alcanzan niveles de IGF-1 en rango medio de normalidad.\nD. En caso de indicar tratamiento con testosterona en hombres, es obligado realizar previamente una valoración del tamaño prostático, PSA y hematocrito.\n\n### COMENTARIO\n\nHay pocas evidencias para tratar a pacientes con hipertiroidismo subclínico que tengan TSH mayor de 0,1 mUI/ml asociado a FT4 normal, pero hay ciertos grupos de pacientes con TSH inferior a 0,1 mUI/ml persistente con FT4 normal que necesitan tratamiento, como son las personas mayores de 65 años, las que padecen osteoporosis posmenopáusica o cardiopatías. En el caso del anciano, el mejor control de la función tiroidea evita problemas como la fibrilación auricular, a la que se encuentran predispuestos en situación de hipertiroidismo subclínico. Aunque se pueda iniciar el tratamiento con medicación antitiroidea a dosis bajas, un planteamiento a más largo plazo dependerá de la causa del hipertiroidismo: en una enfermedad de Basedow podría esperarse una remisión espontánea tras unos meses de tratamiento farmacológico; en cambio, en un bocio multinodular suele indicarse precozmente el I-131, por la baja incidencia de hipotiroidismo después del tratamiento y por la baja probabilidad de remisión espontánea del proceso.\n\nLa terapia hormonal sustitutiva con estrógenos en mujeres en edad posmenopáusica fue utilizada durante años buscando el beneficio cardiovascular, hasta que estudios como el Women's Health Initiative (WHI) en el año 2012 comenzaron a destacar los riesgos inherentes a este tratamiento y la necesidad de individualizarlo. En lo referente al cáncer de mama, este estudio y otros posteriores mostraron que el uso de progestágenos añadido al tratamiento con estrógenos aumenta el riesgo de carcinoma de mama.\n\nLa administración de hormona del crecimiento (GH) a personas mayores se ha propuesto como tratamiento antienvejecimiento, ya que los niveles de IGF-1 bajan de forma fisiológica con la edad, aunque no se trate de una indicación aprobada. Utilizado con este propósito se consigue que la masa grasa total disminuya y aumente la masa magra, sin cambios de peso. Otros resultados no cambian, incluida la densidad ósea y los niveles séricos de lípidos. Pero este tratamiento no es inofensivo, ya que puede asociarse a efectos adversos como edema, síndrome del túnel carpiano, ginecomastia y diabetes mellitus. No se ha demostrado en este tipo de individuos que llevar los niveles de IGF-1 a la normalidad se acompañe de una mejora funcional. Con base en estos hallazgos no se justifica el tratamiento con GH. En cambio, en pacientes con una deficiencia patológica de GH se observa una mejora de la calidad de vida, del rendimiento muscular y de la función neuromuscular.\n\nCuando se inicia la terapia con testosterona, se debe evaluar periódicamente el cumplimiento del tratamiento, su eficacia y la aparición de efectos adversos o contraindicaciones. Al respecto de estos últimos hay que destacar:\n\n- Antes del tratamiento y durante el primer año se vigilarán las concentraciones de PSA y la exploración prostática, y después se seguirá la pauta estándar para la detección del cáncer de próstata, así como el de mama.\n- Por el mayor riesgo de desarrollar el síndrome metabólico (obesidad abdominal, HTA, dislipidemia con descenso de colesterol HDL con hipertrigliceridemia e intolerancia hidrocarbonada o diabetes mellitus) hay que valorar\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}